BMO Capital analyst Etzer Darout has recently started covering Novartis (NYSE:NVS) with a Market Perform rating and a price target
BMO Capital Analyst Initiates Coverage on Novartis with Market Perform Rating and 114 Price Target
Feb 24, 2024
